Proof-of Principle Study Finds Imatinib Improves Symptoms for Patients with Severe Asthma

In a new, proof-of-principle study, researchers found that targeting the mast cells with imatinib, a drug used to effectively treat certain forms of cancer, improved airway hyper responsiveness, and decreased the number of mast cells present.
Source: BWH News - Category: Hospital Management Source Type: news